SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024985
Filing Date
2022-11-14
Accepted
2022-11-14 16:07:21
Documents
16
Period of Report
2022-11-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apgn-20221108.htm   iXBRL 8-K 69518
2 EX-16.1 apgn-ex16_1.htm EX-16.1 9302
3 EX-99.1 apgn-ex99_1.htm EX-99.1 29748
4 GRAPHIC img214223439_0.jpg GRAPHIC 8223
  Complete submission text file 0000950170-22-024985.txt   282864

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apgn-20221108_lab.xml EX-101.LAB 17189
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apgn-20221108.xsd EX-101.SCH 2961
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apgn-20221108_def.xml EX-101.DEF 13750
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apgn-20221108_pre.xml EX-101.PRE 13050
10 EXTRACTED XBRL INSTANCE DOCUMENT apgn-20221108_htm.xml XML 6545
Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39488 | Film No.: 221385173
SIC: 2834 Pharmaceutical Preparations